179 Results for "

Integrin Inhibitor

" in MedChemExpress (MCE) Product Catalog:
Products (179)

179 Results for "Integrin Inhibitor" in MCE Product Catalog:

74
74 Publications Verification
Art. -Nr.: HY-16143
CAS. Nr.: 199807-35-7
Synonyms: EMD 121974 TFA
Target:  

Integrin Autophagy

Forschungsgebiete:  

Cancer

Cilengitide is a potent and selective integrin inhibitor for αvβ3 and αvβ5 receptor, with IC50 values of 4 nM and 79 nM, respectively.
loading...
    loading...
74
74 Publications Verification
Art. -Nr.: HY-16141
CAS. Nr.: 188968-51-6
Synonyms: EMD 121974
Cilengitide (EMD 121974) is a BBB-permeable integrins antagonist with IC50s of 0.61 nM (ανβ3), 8.4 nM (ανβ5) and 14.9 nM (α5β1), respectively. Cilengitide inhibits the binding of ανβ3 and ανβ5 to Vitronectin with IC50s of 4 nM and 79 nM, respectively. Cilengitide inhibits TGF-β/Smad signaling, mediates PD-L1 expression. Cilengitide also induces apoptosis, shows antiangiogenic effect in the research against glioblastoma and other cancers .
loading...
    loading...
32
32 Cited Publications
Art. -Nr.: HY-P0023
CAS. Nr.: 161552-03-0
Target:  

Integrin

Forschungsgebiete:  

Cancer

Cyclo(-RGDfK) is a potent and selective inhibitor of the αvβ3 integrin, with an IC50 of 0.94 nM. Cyclo(-RGDfK) potently targets tumor microvasculature and cancer cells through the specific binding to the αvβ3 integrin on the cell surface .
loading...
    loading...
32
32 Cited Publications
Art. -Nr.: HY-P0023A
CAS. Nr.: 500577-51-5
Target:  

Integrin

Forschungsgebiete:  

Cancer

Cyclo(-RGDfK) TFA is a potent and selective inhibitor of the αvβ3 integrin, with an IC50 of 0.94 nM . Cyclo(-RGDfK) TFA potently targets tumor microvasculature and cancer cells through the specific binding to the αvβ3 integrin on the cell surface .
loading...
    loading...
19
19 Cited Publications
Art. -Nr.: HY-100506
CAS. Nr.: 1320346-97-1
Reinheit:  99.43%
Target:  

Integrin

Forschungsgebiete:  

Cancer

GLPG0187 is a broad spectrum integrin receptor antagonist with antitumor activity; inhibits αvβ1-integrin with an IC50 of 1.3 nM . GLPG0187 inhibits migrasome biogenesis without cytotoxicity .
loading...
    loading...
12
12 Cited Publications
Art. -Nr.: HY-18676
CAS. Nr.: 2070015-22-2
Forschungsgebiete:  

Cancer

OSU-T315 (ILK-IN-1) is a small Integrin-linked kinase (ILK) inhibitor with an IC50 of 0.6 μM, inhibiting PI3K/AKT signaling by dephosphorylation of AKT-Ser473 and other ILK targets (GSK-3β and myosin light chain) . OSU-T315 abrogates AKT activation by impeding AKT localization in lipid rafts and triggers caspase-dependent apoptosis in an ILK-independent manner . OSU-T315 causes cell death through apoptosis and autophagy .
loading...
    loading...
11
11 Cited Publications
Art. -Nr.: HY-13535
CAS. Nr.: 262438-43-7
ATN-161 is an antagonist of α5β1 integrin and αvβ3 integrin, as well as an inhibitor of fibrosis, an inhibitor of oxidative stress, a tight junction stabilizer, a mitochondrial integrity protector, an angiogenesis inhibitor and an antiviral agent. ATN-161 inhibits NLRP3, MAPK, and ROS. ATN-161 protects mice from SARS-CoV-2 infection . ATN-161 reduces infarct volume, alleviates edema, decreases immune cell infiltration, reduces the area of choroidal neovascularization lesions, lowers tumor microvessel density and viral load. ATN-161 can be used in research related to ischemic stroke, choroidal neovascularization, breast cancer, coronavirus disease 2019 (COVID-19), and liver metastasis of colorectal cancer .
loading...
    loading...
11
11 Cited Publications
Art. -Nr.: HY-13535A
CAS. Nr.: 904763-27-5
Reinheit:  99.04%
Synonyms: ATN-161 TFA salt
Target:  

Integrin

Forschungsgebiete:  

Cancer

ATN-161 trifluoroacetate salt is a novel integrin α5β1 antagonist, which inhibits angiogenesis and growth of liver metastases in a murine model.
loading...
    loading...
11
11 Cited Publications
Art. -Nr.: HY-19344
CAS. Nr.: 1025967-78-5
Synonyms: SAR 1118; SHP-606
Target:  

Integrin

Forschungsgebiete:  

Inflammation/Immunology

Lifitegrast (SAR 1118) is a potent integrin antagonist. Lifitegrast blocks the binding of intercellular adhesion molecule 1 (ICAM-1) to lymphocyte function-associated antigen 1 (LFA-1), interrupting the T cell-mediated inflammatory cycle. Lifitegrast inhibits Jurkat T cell attachment to ICAM-1 with an IC50 of 2.98 nM. Lifitegrast can be used for researching dry eye disease .
loading...
    loading...
11
11 Cited Publications
Art. -Nr.: HY-19344A
CAS. Nr.: 1119276-80-0
Synonyms: SAR 1118 sodium; SHP-606 sodium
Target:  

Integrin

Forschungsgebiete:  

Inflammation/Immunology

Lifitegrast (SAR 1118) sodium is a potent integrin antagonist. Lifitegrast sodium blocks the binding of intercellular adhesion molecule 1 (ICAM-1) to lymphocyte function-associated antigen 1 (LFA-1), interrupting the T cell-mediated inflammatory cycle. Lifitegrast sodium inhibits Jurkat T cell attachment to ICAM-1 with an IC50 of 2.98 nM. Lifitegrast sodium can be used for researching dry eye disease .
loading...
    loading...
10
10 Cited Publications
Art. -Nr.: HY-18644
CAS. Nr.: 1564286-55-0
Target:  

Integrin

Forschungsgebiete:  

Cancer

CWHM-12 is a potent inhibitor of αV integrins with IC50s of 0.2, 0.8, 1.5, and 1.8 nM for αvβ8, αvβ3, αvβ6, and αvβ1.
loading...
    loading...
9
9 Cited Publications
Art. -Nr.: HY-12290
CAS. Nr.: 91037-65-9
Reinheit:  99.93%
Synonyms: RGDS peptide; Fibronectin tetrapeptide
Target:  

Integrin

Forschungsgebiete:  

Inflammation/Immunology

Arg-Gly-Asp-Ser is an integrin binding sequence that inhibits integrin receptor function. Arg-Gly-Asp-Ser directly and specifically bind pro-caspase-8, pro-caspase-9 and pro-caspase-3, while it does not bind pro-caspase-1.
loading...
    loading...
9
9 Cited Publications
Art. -Nr.: HY-P1740
CAS. Nr.: 114681-65-1
Target:  

Integrin Apoptosis Caspase

Forschungsgebiete:  

Inflammation/Immunology

RGD peptide (GRGDNP) is an inhibitor of integrin-ligand interactions. RGD peptide (GRGDNP) competitively inhibits α5β1 binding with extracellular matrice (ECM). RGD peptide (GRGDNP) promotes apoptosis through activation of conformation changes that enhance pro-caspase-3 activation and autoprocessing. RGD peptide (GRGDNP) plays an important role in cell adhesion, migration, growth, and differentiation .
loading...
    loading...
9
9 Cited Publications
Art. -Nr.: HY-P1740A
Target:  

Integrin Apoptosis

Forschungsgebiete:  

Inflammation/Immunology Cancer

RGD peptide (GRGDNP) TFA is an inhibitor of integrin-ligand interactions. RGD peptide (GRGDNP) TFA competitively inhibits α5β1 binding with extracellular matrice (ECM). RGD peptide (GRGDNP) TFA promotes apoptosis through activation of conformation changes that enhance pro-caspase-3 activation and autoprocessing. RGD peptide (GRGDNP) TFA plays an important role in cell adhesion, migration, growth, and differentiation .
loading...
    loading...
7
7 Cited Publications
Art. -Nr.: HY-100445A
Reinheit:  98.28%
Target:  

Integrin

Forschungsgebiete:  

Cardiovascular Disease Cancer

αvβ1 integrin-IN-1 TFA (Compound C8) is a potent and selective αvβ1 integrin inhibitor with an IC50 of 0.63 nM. Antifibrotic effects .
loading...
    loading...
7
7 Cited Publications
Art. -Nr.: HY-100445
CAS. Nr.: 1689540-62-2
Reinheit:  99.51%
Target:  

Integrin

Forschungsgebiete:  

Cardiovascular Disease Cancer

αvβ1 integrin-IN-1 (Compound C8) is a potent and selective αvβ1 integrin inhibitor with an IC50 of 0.63 nM. Antifibrotic effects .
loading...
    loading...
6
6 Cited Publications
Art. -Nr.: HY-17369
CAS. Nr.: 150915-40-5
Synonyms: L700462 hydrochloride monohydrate; MK383 hydrochloride monohydrate
Target:  

Integrin

Forschungsgebiete:  

Cardiovascular Disease

Tirofiban (L700462) hydrochloride monohydrate is a selective and reversible platelet integrin receptor (Gp IIb/IIIa) antagonist that inhibits fibrinogen binding to this receptor and has antithrombotic activity. Tirofiban hydrochloride monohydrate induces proliferation and migration on endothelial cell by inducing production of VEGF. Tirofiban hydrochloride monohydrate can significantly reduces myocardial no-reflow and ischemia-reperfusion injury by alleviating myocardial microvascular structural and endothelial dysfunction in the ischemic area .
loading...
    loading...
6
6 Cited Publications
Art. -Nr.: HY-17369B
CAS. Nr.: 144494-65-5
Synonyms: L700462; MK383
Target:  

Integrin

Forschungsgebiete:  

Cardiovascular Disease

Tirofiban (L700462) is a selective and reversible platelet integrin receptor (Gp IIb/IIIa) antagonist that inhibits fibrinogen binding to this receptor and has antithrombotic activity. Tirofiban induces proliferation and migration on endothelial cell by inducing production of VEGF. Tirofiban can significantly reduces myocardial no-reflow and ischemia-reperfusion injury by alleviating myocardial microvascular structural and endothelial dysfunction in the ischemic area .
loading...
    loading...
5
5 Cited Publications
Art. -Nr.: HY-P0290
CAS. Nr.: 91037-75-1
Target:  

Integrin

Forschungsgebiete:  

Cancer

GRGDSP, a synthetic linear RGD peptide, is an integrin inhibitor.
loading...
    loading...
5
5 Cited Publications
Art. -Nr.: HY-P0290A
Target:  

Integrin

Forschungsgebiete:  

Cancer

GRGDSP (TFA) is an integrin inhibitor.
loading...
    loading...